Clinical trials
Esophagitis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 5 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Terminated | 7 |
| Unknown status | 4 |
| Recruiting | 2 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
| No longer available | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ellodi Pharmaceuticals, LP | 4 |
| Pfizer | 3 |
| University of Utah | 3 |
| Boston Children's Hospital | 2 |
| Celgene | 2 |
| EndoGastric Solutions | 2 |
| M.D. Anderson Cancer Center | 2 |
| Medical College of Wisconsin | 2 |
| Adare Pharmaceuticals, Inc. | 1 |
| Allakos Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophagitis | 56 |
| Eosinophilic Esophagitis | 21 |
| Gastroesophageal Reflux | 16 |
| Esophageal Diseases | 11 |
| Gastrointestinal Diseases | 10 |
| Digestive System Diseases | 7 |
| Eosinophilia | 7 |
| Gastroenteritis | 7 |
| Heartburn | 6 |
| Hypersensitivity | 6 |
Trials
Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.